Home » Cytox Launches Genetic Test for Alzheimer’s Disease
Cytox Launches Genetic Test for Alzheimer’s Disease
Cytox has launched Variatech, a diagnostic test for Alzheimer’s Disease that relies on genetic biomarkers.
The blood-based test provides a comprehensive panel of AD informative SNPs to assist research and novel drug discovery studies.
Company studies indicate it has an accuracy rate over 80 percent. — Cynthia Jessup
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May